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INTRODUCTION 
In vaccines, proteins are often utilized as the antigen, 
although these are generally poorly immunogenic. To 
overcome this, the antigen is incorporated into a particulate 
system, often together with adjuvants. More specifically, 
lipid-based particulates such as cubosomes have been 
proven useful as a potential carrier for vaccines [Rizwan et 
al., 2013]. Cubosomes consist of a highly twisted, 
continuous lipid bilayer and two congruent, non-
intersecting water channels, providing both hydrophilic and 
hydrophobic domains and a large surface area for 
association of antigens [Rizwan et al., 2011].  
Cell culture-based in vitro models are a very important 
alternative and supplement to animal testing, and 
combining various cell types together in one model can 
improve the correlation with in vivo studies [Susewind et 
al., 2015]. A triple co-culture cell model of Caco-2 cells, 
dendritic cells and macrophages (Figure 1), has previously 
been developed for studying intestinal permeability in a 
state of inflammation [Leonard et al., 2010], [Susewind et 
al., 2015].  
The aim of this study was to investigate the applicability of 
this cell model for testing the immunostimulatory ability of 
particulate vaccine formulations designed for oral delivery. 
Levels of cytokine production in response to vaccine 
administration were measured following particulate vaccine 
administration, as an indication of dendritic cell and 
macrophage activation. Cubosomes containing the model 
antigen ovalbumin was spray dried to obtain a particulate 
vaccine model system for testing in the cell model.  
 
 
 
Figure 1: Schematic of the triple co-culture model being 
adapted for oral vaccine delivery.   
 
EXPERIMENTAL  
THP-1 cells were differentiated to macrophages, and 
MUTZ-3 cells grew dendritic cell-like characteristics. The 
cells were pre-stained and added to a solution of bovine 
collagen with human serum and Roswell Park Memorial 
Institute medium. The solution was pipetted into the apical 
compartment of a transwell filter insert, and incubated until 
the collagen layer solidified. Subsequently, Caco-2 (clone 
HTB37) cells in medium were seeded on top of the collagen 
layer. Medium was added to the basolateral compartment, 
and the co-cultures were grown for approximately 11 days 
(Figure 1). Transepithelial electrical resistance (TEER) was 
measured in each well during the 11 days of growth.    
Precursors of cubosomes, consisting of the lipid dimodan, 
loaded with ovalbumin as a model antigen and with a 
surrounding dextran shell were prepared by spray drying. 
Dimodan and rhodamine dissolved in ethanol (1.78 w/v%) 
was first mixed with a solution of ovalbumin in water 
(0.075 final w/w% of ovalbumin). After 1h of mixing, 
dextran dissolved in water (1.77 w/v%) was added to the 
lipid/ovalbumin solution (0.72 w/w% of lipid + ovalbumin), 
and the final solution was spray dried on a Büchi mini spray 
dryer (Figure 2). Cryo-TEM was utilized to identify the 
cubic phase of the spray dried product. In addition, SAXS 
experiments were performed on a SAXS/WAXS beamline 
at the Australian Synchrotron. Hydrated cubosomes were 
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enclosed in glass capillaries and 2D SAXS patterns were 
collected. 
Spray drying
Cubosomes with OVA covered
with dextran 
Dimodan + OVA + 
EtOH + dextran + water
Rhodamine + 
Dimodan + 
OVA + EtOH
+
Dextran + 
water
 
Figure 2: Spray drying of precursors of cubosomes containing 
ovalbumin.  
 
On the day of experiments, vaccine formulations (Table 1) 
were added to the apical side of co-cultures and incubated 
at 37°C. After 4 and 24 hours, samples were taken out of 
the apical compartment and stored at -80°C until further 
analysis. After 24 hours (end of study), the cells were fixed 
and the Caco-2 cells were stained. The co-cultures were 
investigated under a confocal laser scanning microscope. 
The apical samples were analysed using a multi-analyte 
ELISArray kit to screen for produced cytokines.  
 
Formulation Concentration 
Blank (only buffer) - 
Ovalbumin solution 500 µg/mL 
Blank cubosomes 10 mg of dry particles 
Cubosomes with ovalbumin 5 mg of dry particles 
Lipopolysaccharide (LPS) 10 µg/mL 
Table 1: Formulations to be tested on the co-culture model. 
 
RESULTS 
The precursors were shown to form cubosomes when 
dispersed in aqueous medium (Figure 3), and was therefore 
used as the vaccine formulation for testing on the co-
cultures.  
A) B)
 
Figure 3: A) Cryo-TEM results confirmed the cubic structure 
of the particles. B) SAXS patterns also verified the cubic 
structure. 
 
After 11 days, the TEER values of the co-cultures were 
found to be 860-1340 Ω∙cm2; the formulations were 
incubated with the co-cultures at this time point. From the 
confocal microscopy images (Figure 4), it can be observed 
that the THP-1 cells (macrophages – green cells) migrated 
into the overlying Caco-2 cell monolayer when the co-
cultures were incubated with particle formulations. This 
was not the case when incubating with ovalbumin solution 
or blank.  
 
A) B) C)
 
Figure 4: Confocal microscopy images of the co-cultures with 
Caco-2 cell nuclei in blue, THP-1 cells in green and MUTZ-3 
cells in dark red. Images: A): OVA cubosomes 5 mg, 4h B): 
LPS 10 ug/mL 4h, C): 24 h blank sample 
 
The ELISA screening assay showed production of a wide 
range of cytokines following culture incubation with 
cubosomes (with and without ovalbumin) and LPS 
solutions, indicative of a stimulatory effect; this was not 
observed with ovalbumin and blank solution. Example 
results are shown in Figure 5 for IL-2 and IL-17A.    
 
Figure 5: Examples of cytokine production of IL-2 and IL-17A 
after incubation of formulation with the co-cultures for 4 or 
24h.  
 
CONCLUSION 
An established co-culture of Caco-2, THP-1 and MUTZ-3 
cells showed promise as an in vitro model for testing of oral 
vaccine formulations. Mobility of co-culture immune cells 
as well as cytokine production observed following 
treatment with spray dried cubosomes as a particulate 
vaccine formulation will be further investigated.  
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